Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Comparison of the 4-Digit Code, Canadian 2015, Australian 2016 and Hoyme 2016 fetal alcohol spectrum disorder diagnostic guidelines.

Hemingway SJA, Bledsoe JM, Brooks A, Davies JK, Jirikowic T, Olson E, Thorne JC.

Adv Pediatr Res. 2019;6(2). pii: 31. doi: 10.35248/2385-4529.19.6.31. Epub 2019 Oct 17.

2.

Prevalence and Characteristics of Metabolic Syndrome Differ in Men and Women with Early Rheumatoid Arthritis.

Kuriya B, Schieir O, Valois MF, Pope JE, Boire G, Bessette L, Hazlewood G, Thorne JC, Tin D, Hitchon C, Bartlett SJ, Keystone EC, Bykerk VP, Barra L; CATCH investigators.

ACR Open Rheumatol. 2019 Aug 28;1(9):535-541. doi: 10.1002/acr2.11075. eCollection 2019 Nov. Erratum in: ACR Open Rheumatol. 2020 Jan;2(1):61. Bartlett, S [corrected to Bartlett, SJ].

3.

2019 American College of Rheumatology Recommended Patient-Reported Functional Status Assessment Measures in Rheumatoid Arthritis.

Barber CEH, Zell J, Yazdany J, Davis AM, Cappelli L, Ehrlich-Jones L, Everix D, Thorne JC, Bohm V, Suter L, Limanni A, Michaud K.

Arthritis Care Res (Hoboken). 2019 Dec;71(12):1531-1539. doi: 10.1002/acr.24040. Epub 2019 Nov 11.

PMID:
31709771
4.

Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort.

Sepriano A, Ramiro S, FitzGerald O, Østergaard M, Homik J, van der Heijde D, Elkayam O, Thorne JC, Larché MJ, Ferraccioli G, Backhaus M, Burmester GR, Boire G, Combe B, Schaeverbeke T, Saraux A, Dougados M, Rossini M, Govoni M, Sinigaglia L, Cantagrel A, Barnabe C, Bingham CO 3rd, Tak PP, van Schaardenburg D, Berner Hammer H, Paschke J, Dadashova R, Hutchings E, Landewé R, Maksymowych WP.

J Rheumatol. 2019 Sep 15. pii: jrheum.190303. doi: 10.3899/jrheum.190303. [Epub ahead of print]

PMID:
31523049
5.

Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RA.

Maksymowych WP, FitzGerald O, Østergaard M, Homik J, van der Heijde D, Lambert RG, Elkayam O, Ramiro S, Thorne JC, Larché MJ, Ferraccioli G, Backhaus M, Burmester GR, Boire G, Combe B, Schaeverbeke T, Saraux A, Dougados M, Rossini M, Govoni M, Sinigaglia L, Cantagrel A, Barnabe C, Bingham CO 3rd, Tak PP, van Schaardenburg D, Berner Hammer H, Paschke J, Dadashova R, Hutchings E, Sepriano A, Landewé R.

J Rheumatol. 2019 Sep 1. pii: jrheum.190302. doi: 10.3899/jrheum.190302. [Epub ahead of print]

PMID:
31474600
6.

Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care.

Barber CEH, Lix LM, Lacaille D, Marshall DA, Kroeker K, Benseler S, Twilt M, Schmeling H, Barnabe C, Hazlewood GS, Bykerk V, Homik J, Thorne JC, Burt J, Mosher D, Katz S, Shiff NJ.

BMC Health Serv Res. 2019 Aug 14;19(1):572. doi: 10.1186/s12913-019-4379-4.

7.

Encounters with Rheumatologists in a Publicly Funded Canadian Healthcare System: A Population-based Study.

Widdifield J, Bernatsky S, Pope JE, Ahluwalia V, Barber CEH, Eder L, Kuriya B, Ling V, Paterson JM, Thorne JC.

J Rheumatol. 2019 Jun 15. pii: jrheum.190034. doi: 10.3899/jrheum.190034. [Epub ahead of print]

8.

Quality and continuity of information between primary care physicians and rheumatologists.

Wong J, Tu K, Bernatsky S, Jaakkimainen L, Thorne JC, Ahluwalia V, Paterson JM, Widdifield J.

BMC Rheumatol. 2019 May 24;3:1. doi: 10.1186/s41927-019-0067-6. eCollection 2019. Erratum in: BMC Rheumatol. 2019 Aug 20;3:35.

9.

Listening Difficulties in Children With Fetal Alcohol Spectrum Disorders: More Than a Problem of Audibility.

McLaughlin SA, Thorne JC, Jirikowic T, Waddington T, Lee AKC, Astley Hemingway SJ.

J Speech Lang Hear Res. 2019 May 21;62(5):1532-1548. doi: 10.1044/2018_JSLHR-H-18-0359.

PMID:
31039324
10.

Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results.

Lau AN, Thorne JC, Movahedi M, Rampakakis E, Cesta A, Li X, Couto S, Sampalis J, Bombardier C; OBRI Investigators.

J Rheumatol. 2019 Aug;46(8):874-886. doi: 10.3899/jrheum.180486. Epub 2019 Apr 15.

PMID:
30988121
11.

A Systematic Review and Appraisal of the Cross-Cultural Validity of Functional Status Assessments Measures in Rheumatoid Arthritis.

Kulhawy-Wibe SC, Zell J, Michaud K, Yazdany J, Davis AM, Ehrlich-Jones L, Thorne JC, Everix D, Cappelli LC, Suter LG, Limanni A, Barber CEH.

Arthritis Care Res (Hoboken). 2019 Apr 12. doi: 10.1002/acr.23904. [Epub ahead of print]

PMID:
30980507
12.

Associations Between Methotrexate Use and the Risk of Cardiovascular Events in Patients with Elderly-onset Rheumatoid Arthritis.

Widdifield J, Abrahamowicz M, Paterson JM, Huang A, Thorne JC, Pope JE, Kuriya B, Beauchamp ME, Bernatsky S.

J Rheumatol. 2019 May;46(5):467-474. doi: 10.3899/jrheum.180427. Epub 2018 Dec 1.

PMID:
30504508
13.

Treatment of rheumatoid arthritis in the USA: premature use of tumor necrosis factor inhibition and underutilization of concomitant methotrexate.

O'Dell JR, Cohen SB, Thorne JC, Kremer J.

Open Access Rheumatol. 2018 Jul 3;10:97-101. doi: 10.2147/OARRR.S169152. eCollection 2018.

14.

Feasibility of Measurement and Adherence to System Performance Measures for Rheumatoid Arthritis in 5 Models of Care.

Barber CEH, Thorne JC, Ahluwalia V, Burt J, Lacaille D, Marshall DA, Hazlewood GS, Mosher D, Denning L, Szamko I, Chin R, Hamilton S, Benseler S, Twilt M, Shiff NJ, Bykerk V, Homik J, Barnabe C.

J Rheumatol. 2018 Nov;45(11):1501-1508. doi: 10.3899/jrheum.171284. Epub 2018 Jun 15.

PMID:
29907674
15.

Planning for the Rheumatologist Workforce: Factors Associated With Work Hours and Volumes.

Barber CEH, Nasr M, Barnabe C, Badley EM, Lacaille D, Pope J, Cividino A, Yacyshyn E, Baillie C, Mosher D, Thomson JG, Charnock C, Thorne JC, Zummer M, Brophy J, Ruban TN, Ahluwalia V, McDougall R, Marshall DA.

J Clin Rheumatol. 2019 Apr;25(3):142-146. doi: 10.1097/RHU.0000000000000803.

PMID:
29846270
16.

Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION Study.

Marshall JK, Bessette L, Shear NH, Lebovic G, Glass J, Millson B, Gaetano T, Gazel S, Latour MG, Laliberté MC, Thorne JC.

Clin Ther. 2018 Jun;40(6):1024-1032. doi: 10.1016/j.clinthera.2018.04.017. Epub 2018 May 24.

17.

High Adherence to System-Level Performance Measures for Rheumatoid Arthritis in a National Early Arthritis Cohort Over Eight Years.

Barber CEH, Schieir O, Lacaille D, Marshall DA, Barnabe C, Hazlewood G, Thorne JC, Ahluwalia V, Bartlett SJ, Boire G, Haraoui B, Hitchon C, Keystone E, Tin D, Pope JE, Denning L, Bykerk VP; Canadian Early Arthritis Cohort Investigators.

Arthritis Care Res (Hoboken). 2018 Jun;70(6):842-850. doi: 10.1002/acr.23439. Epub 2018 Mar 25.

19.

Overweight, Obesity, and the Likelihood of Achieving Sustained Remission in Early Rheumatoid Arthritis: Results From a Multicenter Prospective Cohort Study.

Schulman E, Bartlett SJ, Schieir O, Andersen KM, Boire G, Pope JE, Hitchon C, Jamal S, Thorne JC, Tin D, Keystone EC, Haraoui B, Goodman SM, Bykerk VP; CATCH Investigators.

Arthritis Care Res (Hoboken). 2018 Aug;70(8):1185-1191. doi: 10.1002/acr.23457. Epub 2018 Jul 13.

20.

Early Rheumatoid Arthritis Presentation, Treatment, and Outcomes in Aboriginal Patients in Canada: A Canadian Early Arthritis Cohort Study Analysis.

Nagaraj S, Barnabe C, Schieir O, Pope J, Bartlett SJ, Boire G, Keystone E, Tin D, Haraoui B, Thorne JC, Bykerk VP, Hitchon C; Canadian Early Arthritis Cohort Study Investigators.

Arthritis Care Res (Hoboken). 2018 Aug;70(8):1245-1250. doi: 10.1002/acr.23470.

21.

Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.

Kuriya B, Schieir O, Lin D, Xiong J, Pope J, Boire G, Haraoui B, Thorne JC, Tin D, Hitchon C, Jamal S, Keystone E, Bykerk VP; CATCH Investigators.

Clin Exp Rheumatol. 2017 Sep-Oct;35(5):799-803. Epub 2017 Mar 23.

PMID:
28339365
22.

Primary Care Screening and Comorbidity Management in Rheumatoid Arthritis in Ontario, Canada.

Widdifield J, Ivers NM, Bernatsky S, Jaakkimainen L, Bombardier C, Thorne JC, Ahluwalia V, Paterson JM, Young J, Wing L, Tu K.

Arthritis Care Res (Hoboken). 2017 Oct;69(10):1495-1503. doi: 10.1002/acr.23178. Epub 2017 Aug 22.

23.

Stand Up and Be Counted: Measuring and Mapping the Rheumatology Workforce in Canada.

Barber CE, Jewett L, Badley EM, Lacaille D, Cividino A, Ahluwalia V, Averns H, Baillie C, Ellsworth J, Pope J, Levy D, Charnock C, McGowan C, Thorne JC, Barnabe C, Zummer M, Lundon K, McDougall RS, Thomson JG, Yacyshyn EA, Mosher D, Brophy J, Ruban TN, Marshall DA.

J Rheumatol. 2017 Feb;44(2):248-257. doi: 10.3899/jrheum.160621. Epub 2016 Dec 1.

PMID:
27909087
24.
25.

Underuse of Methotrexate in the Treatment of Rheumatoid Arthritis: A National Analysis of Prescribing Practices in the US.

Rohr MK, Mikuls TR, Cohen SB, Thorne JC, O'Dell JR.

Arthritis Care Res (Hoboken). 2017 Jun;69(6):794-800. doi: 10.1002/acr.23152. Epub 2017 Apr 24.

26.

Development and Alpha-testing of a Stepped Decision Aid for Patients Considering Nonsurgical Options for Knee and Hip Osteoarthritis Management.

Toupin April K, Rader T, Hawker GA, Stacey D, O'Connor AM, Welch V, Lyddiatt A, McGowan J, Thorne JC, Bennett C, Pardo Pardo J, Wells GA, Tugwell P.

J Rheumatol. 2016 Oct;43(10):1891-1896. Epub 2016 Sep 1.

PMID:
27585691
27.

Predicting Low Disease State and Remission in Early Rheumatoid Arthritis in the First Six Months, Comparing the Simplified Disease Activity Index and European League Against Rheumatism Response Measures: Results From an Early Arthritis Cohort.

Omair MA, Keystone E, Bykerk V, Lin D, Xiong J, Sun Y, Boire G, Thorne JC, Tin D, Pope J, Hitchon C, Haraoui B, Akhavan PS; Canadian Early Arthritis Cohort Investigators.

Arthritis Care Res (Hoboken). 2017 May;69(5):737-741. doi: 10.1002/acr.22983. Epub 2017 Apr 7.

28.

Wait times to rheumatology care for patients with rheumatic diseases: a data linkage study of primary care electronic medical records and administrative data.

Widdifield J, Bernatsky S, Thorne JC, Bombardier C, Jaakkimainen RL, Wing L, Paterson JM, Ivers N, Butt D, Lyddiatt A, Hofstetter C, Ahluwalia V, Tu K.

CMAJ Open. 2016 May 11;4(2):E205-12. doi: 10.9778/cmajo.20150116. eCollection 2016 Apr-Jun.

29.

Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set.

Bykerk VP, Bingham CO, Choy EH, Lin D, Alten R, Christensen R, Furst DE, Hewlett S, Leong A, March L, Woodworth T, Boire G, Haraoui B, Hitchon C, Jamal S, Keystone EC, Pope J, Tin D, Thorne JC, Bartlett SJ.

RMD Open. 2016 May 26;2(1):e000225. doi: 10.1136/rmdopen-2015-000225. eCollection 2016.

30.

Exploring the Utility of a School-Age Narrative Microstructure Index: Proportion of Restricted Utterances.

Jerger S, Thorne JC.

Lang Speech Hear Serv Sch. 2016 Apr 1;47(2):171-80. doi: 10.1044/2015_LSHSS-15-0021.

PMID:
27045171
31.

Two-year radiographic and clinical outcomes from the Canadian Methotrexate and Etanercept Outcome study in patients with rheumatoid arthritis.

Keystone EC, Pope JE, Thorne JC, Poulin-Costello M, Phan-Chronis K, Vieira A, Haraoui B; CAMEO Investigators.

Rheumatology (Oxford). 2016 Feb;55(2):327-34. doi: 10.1093/rheumatology/kev338. Epub 2015 Sep 11.

32.

Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.

Shu J, Bykerk VP, Boire G, Haraoui B, Hitchon C, Thorne JC, Tin D, Keystone EC, Pope JE; CATCH Investigators.

J Rheumatol. 2015 Nov;42(11):2023-8. doi: 10.3899/jrheum.150260. Epub 2015 Sep 1.

PMID:
26329342
33.

Heterogeneous Disease Trajectories Explain Variable Radiographic, Function and Quality of Life Outcomes in the Canadian Early Arthritis Cohort (CATCH).

Barnabe C, Sun Y, Boire G, Hitchon CA, Haraoui B, Thorne JC, Tin D, van der Heijde D, Curtis JR, Jamal S, Pope JE, Keystone EC, Bartlett S, Bykerk VP; CATCH Investigators.

PLoS One. 2015 Aug 24;10(8):e0135327. doi: 10.1371/journal.pone.0135327. eCollection 2015.

34.

Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients.

Curtis JR, Yang S, Chen L, Pope JE, Keystone EC, Haraoui B, Boire G, Thorne JC, Tin D, Hitchon CA, Bingham CO 3rd, Bykerk VP.

Arthritis Care Res (Hoboken). 2015 Oct;67(10):1345-53. doi: 10.1002/acr.22606.

35.

The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis.

Hazlewood GS, Thorne JC, Pope JE, Lin D, Tin D, Boire G, Haraoui B, Hitchon CA, Keystone EC, Jamal S, Bykerk VP; CATCH Investigators.

Ann Rheum Dis. 2016 Jun;75(6):1003-8. doi: 10.1136/annrheumdis-2014-206504. Epub 2015 May 15.

PMID:
25979945
36.

Trends in Excess Mortality Among Patients With Rheumatoid Arthritis in Ontario, Canada.

Widdifield J, Bernatsky S, Paterson JM, Tomlinson G, Tu K, Kuriya B, Thorne JC, Pope JE, Hollands S, Bombardier C.

Arthritis Care Res (Hoboken). 2015 Aug;67(8):1047-53. doi: 10.1002/acr.22553.

37.

Arthritis clinical trials at a crossroad.

Pope JE, Thorne JC, Haraoui BP, Karsh J, Keystone EC, Bennett L.

J Rheumatol. 2015 Jan;42(1):14-7. doi: 10.3899/jrheum.140717. No abstract available.

PMID:
25554805
38.

Does socioeconomic status affect outcomes in early inflammatory arthritis? Data from a canadian multisite suspected rheumatoid arthritis inception cohort.

Yang G, Bykerk VP, Boire G, Hitchon CA, Thorne JC, Tin D, Haraoui B, Keystone EC, Pope JE; CATCH Investigators.

J Rheumatol. 2015 Jan;42(1):46-54. doi: 10.3899/jrheum.131382. Epub 2014 Nov 15.

PMID:
25399388
39.

Methotrexate use in a breastfeeding patient with rheumatoid arthritis.

Thorne JC, Nadarajah T, Moretti M, Ito S.

J Rheumatol. 2014 Nov;41(11):2332. doi: 10.3899/jrheum.140263. No abstract available.

PMID:
25362724
40.

Is structural damage evaluation by traditional radiographs still relevant in rheumatoid arthritis clinical trials?

Haraoui B, Karsh J, Pope JE, Thorne JC, Keystone EC.

J Rheumatol. 2014 Nov;41(11):2325. doi: 10.3899/jrheum.140383. No abstract available.

PMID:
25362720
41.

Effect of age at menopause on disease presentation in early rheumatoid arthritis: results from the Canadian Early Arthritis Cohort.

Wong LE, Huang WT, Pope JE, Haraoui B, Boire G, Thorne JC, Hitchon CA, Tin D, Keystone EC, Bykerk VP; Canadian Early Arthritis Cohort Investigators.

Arthritis Care Res (Hoboken). 2015 May;67(5):616-23. doi: 10.1002/acr.22494.

42.

Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis--results from the Canadian Early Arthritis Cohort (CATCH).

Kuriya B, Xiong J, Boire G, Haraoui B, Hitchon C, Pope J, Thorne JC, Tin D, Keystone EC, Bykerk V; CATCH Investigators.

J Rheumatol. 2014 Nov;41(11):2161-6. doi: 10.3899/jrheum.140137. Epub 2014 Oct 1.

PMID:
25274902
43.

Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis.

Barra L, Pope JE, Orav JE, Boire G, Haraoui B, Hitchon C, Keystone EC, Thorne JC, Tin D, Bykerk VP; CATCH Investigators.

J Rheumatol. 2014 Dec;41(12):2361-9. doi: 10.3899/jrheum.140082. Epub 2014 Oct 1.

PMID:
25274884
44.

An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: the influence of the reference standard on algorithm performance.

Widdifield J, Bombardier C, Bernatsky S, Paterson JM, Green D, Young J, Ivers N, Butt DA, Jaakkimainen RL, Thorne JC, Tu K.

BMC Musculoskelet Disord. 2014 Jun 23;15:216. doi: 10.1186/1471-2474-15-216.

45.

The epidemiology of rheumatoid arthritis in Ontario, Canada.

Widdifield J, Paterson JM, Bernatsky S, Tu K, Tomlinson G, Kuriya B, Thorne JC, Bombardier C.

Arthritis Rheumatol. 2014 Apr;66(4):786-93. doi: 10.1002/art.38306.

46.

The rising burden of rheumatoid arthritis surpasses rheumatology supply in Ontario.

Widdifield J, Paterson JM, Bernatsky S, Tu K, Thorne JC, Ahluwalia V, Ivers N, Butt D, Jaakkimainen RL, Tomlinson G, Bombardier C.

Can J Public Health. 2013 Oct 31;104(7):e450-5.

47.

Access to rheumatologists among patients with newly diagnosed rheumatoid arthritis in a Canadian universal public healthcare system.

Widdifield J, Paterson JM, Bernatsky S, Tu K, Thorne JC, Ivers N, Butt D, Jaakkimainen RL, Gunraj N, Ahluwalia V, Bombardier C.

BMJ Open. 2014 Jan 31;4(1):e003888. doi: 10.1136/bmjopen-2013-003888.

48.

Determining best practices in early rheumatoid arthritis by comparing differences in treatment at sites in the Canadian Early Arthritis Cohort.

Harris JA, Bykerk VP, Hitchon CA, Keystone EC, Thorne JC, Boire G, Haraoui B, Hazlewood G, Bonner AJ, Pope JE; CATCH Investigators.

J Rheumatol. 2013 Nov;40(11):1823-30. doi: 10.3899/jrheum.121316. Epub 2013 Sep 15.

PMID:
24037554
49.

Clinical utility of the Hospital Anxiety and Depression Scale (HADS) for an outpatient fibromyalgia education program.

Nam S, Tin D, Bain L, Thorne JC, Ginsburg L.

Clin Rheumatol. 2014 May;33(5):685-92. doi: 10.1007/s10067-013-2377-1. Epub 2013 Sep 1.

PMID:
23995734
50.

The Canadian methotrexate and etanercept outcome study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritis.

Pope JE, Haraoui B, Thorne JC, Vieira A, Poulin-Costello M, Keystone EC.

Ann Rheum Dis. 2014 Dec;73(12):2144-51. doi: 10.1136/annrheumdis-2013-203684. Epub 2013 Aug 26.

Supplemental Content

Loading ...
Support Center